Lazard Asset Management LLC Meridian Bioscience Inc Transaction History

Lazard Asset Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $126,780 - $135,897	4,070 New	4,070 $135,000
Q2 2022 Aug 09, 2022	BUY	$23.75 - $31.69 $92,173 - $122,988	3,881 Added 13860.71%	3,909 $118,000
Q1 2022 May 13, 2022	SELL	$19.97 - $26.94 $73,948 - $99,758	-3,703 Reduced 99.25%	28 $0
Q4 2021 Feb 09, 2022	BUY	$17.46 - $21.61 $6,250 - $7,736	358 Added 10.61%	3,731 $76,000
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $884 - $1,147	-51 Reduced 1.49%	3,373 $64,000
Q2 2021 Aug 12, 2021	SELL	$18.01 - $28.32 $96,461 - $151,681	-5,356 Reduced 61.0%	3,424 $75,000
Q1 2021 May 14, 2021	BUY	$19.76 - $29.89 $67,638 - $102,313	3,423 Added 63.9%	8,780 $230,000
Q4 2020 Feb 11, 2021	SELL	$15.73 - $21.66 $755 - $1,039	-48 Reduced 0.89%	5,357 $100,000
Q3 2020 Nov 13, 2020	SELL	$13.54 - $26.41 $3,087 - $6,021	-228 Reduced 4.05%	5,405 $91,000
Q2 2020 Aug 13, 2020	BUY	$7.84 - $23.29 $172 - $512	22 Added 0.39%	5,633 $131,000
Q1 2020 May 14, 2020	BUY	$5.57 - $11.5 $19,266 - $39,778	3,459 Added 160.73%	5,611 $47,000
Q4 2019 Feb 13, 2020	BUY	$7.9 - $10.14 $1,556 - $1,997	197 Added 10.08%	2,152 $21,000
Q3 2019 Nov 14, 2019	BUY	$9.17 - $12.01 $17,927 - $23,479	1,955 New	1,955 $18,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.